Bull & Bear

Bull and Bear

Verdict: Lean Long, Wait For Confirmation — the structural case (SUSS-like economics at a third of the multiple, a dated LAB/DTB shipment ladder, an 18%-of-cap net-cash cushion, and a maiden buyback) is the more credible long-term story, but Bull and Bear are arguing about the same Q1 FY2026 print, and that print is a 1.4% operating margin that mathematically breaks the guide unless H2 inflects.

The debate is not whether advanced packaging is the right end-market, nor whether the balance sheet is clean. Both sides concede those. The debate is whether FY2026 is a transition cost (Bull's FY2019-style trough that re-rates into the FY2027 LAB/DTB ramp) or the leading edge of a structurally lower margin and a permanent loss of the cleaning franchise. The single piece of evidence that resolves it is the Q2 and Q3 FY2026 operating margin. If margin recovers above 10% by Q3, Bull's mix-shift framing is in actuals and the 9× trailing multiple looks like the trap Bear thought Bull had fallen into. If a second sub-5% quarter prints, the guide gets cut, forward P/E recalibrates to 25×+, and Bear's ¥1,800 anchor becomes the relevant gravity.

Bull Case

Bull target: ¥4,500 via through-cycle normalized EPS of ¥260 (mid-point of FY2024 peak ¥289 and FY2025 actual ¥244) × 15× P/E (halfway from current 13× toward the SUSS 18-22× band) plus net cash, cross-checked against Jefferies' ¥4,000 (Buy, January 2026) and an SOTP that values the advanced-packaging book at SUSS's ~2.0× sales. Timeline 12–18 months, with the first re-rating window at Q2 FY2026 results (mid-August 2026). Disconfirming signal: Q2 FY2026 OP margin below 5% and backlog below ¥15B at quarter-end, or a slip of the first LAB shipment to FY2027 — any of which forces an exit.

Bear Case

Bear anchor: ¥1,800 via 13× forward P/E applied to bear-case FY2026 EPS of ¥138 (calibrated to Q1 net income of ¥111M annualizing under ¥0.5B before any margin recovery, -19% vs the ¥170 guide), cross-checked against book value floor of ¥1,834 — small-cap specialists with broken guidance and no services tail historically trade at or below book during a trough. Implies -44% from ¥3,195 if conditions confirm. Timeline 12–18 months. Cover signal: Q2 FY2026 OP margin ≥10% and end-FY2026 backlog stabilized above ¥22B — that combination would mean H2 recovery is in actuals, bonder/debonder demand pull is real, and the mix-shift compression has bottomed.

The Real Debate

Verdict

Lean Long, Wait For Confirmation. Bull carries more weight on the durable variables — the SUSS multiple gap is real and quantified at the same operating margin, the segment mix shift is already 16 points into the bonder/debonder transition, the balance sheet absorbs the ¥7B capex without strain, and the maiden buyback is the clearest signal that management treats this as a trough rather than a structural impairment. The decisive tension is whether Q1 FY2026's 1.4% operating margin is a transition cost or a new run-rate, and Bear has the better near-term framing: 13.4% average across the next three quarters from a 1.4% base is genuinely demanding, and a guidance cut would mechanically reprice the forward multiple before any LAB qualification helps. Bear could still be right if the cleaning collapse is permanent share loss rather than mix shift and the ¥7B capex lands ahead of demand — that combination would compress equity toward book value (¥1,834) regardless of how cheap the trailing multiple looks. Durable thesis breaker: a slip of the first LAB shipment past early 2026, or end-FY2026 backlog below ¥15B — either invalidates the advanced-packaging re-rating mechanism Bull is paying for. Near-term evidence marker (Q2 FY2026 kessan tanshin, mid-August 2026): operating margin path from 1.4% — above 10% confirms the H2 recovery slope and supports a re-rating; below 5% forces the guidance cut Bear is positioned for. Patience on this name is more institutional than conviction either direction.